Skip to main content

Cardiology Update London 2024

-
City
London, UK
Type of event
on site

Invitation

09.12.2024 - 10.12.2024 | The Royal Society of Medicine, London UK

Dear Colleagues

It is a real pleasure to announce the 8th Christmas Postgraduate Course of the Royal Brompton and Harefield Hospitals, belonging to the Guy’s and St. Thomas’ NHS Foundation Trust, and Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the broad spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.
 

Prof. Thomas F. Lüscher
MD, FRPC, FESC

Dr. Peter Libby
FESC, FACC

Prof. Bernard J. Gersh   
FACC

Dr. Richard Grocott-Mason
MD, FRCP

Dr. Eleanor Wicks
FESC


Programme Overview

Monday , December 9th(UK Time)Tuesday, December 10th (UK Time)
8:30

Welcome Address
Opening Lectures

  • Obesity
  • Artificial Intelligence

 

 

 

8:30

Session 4
ACS and Cardiogenic Shock

  • Towards a new classification of MI
  • Preventive PCI or medical therapy 
  • Multivessel ACS
  • Cardiogenic shock
  • DAPT vs SAPT after ACS
9:45Coffee10:30Coffee
10:15

Session 1
Risk Factors and Prevention

  • Lipid management
  • Role of triglycerides
  • Diabetes
  • SGLT2 inhibitors, GLP1/GIP or both?
  • Global risk factor assessment
11:00

Session 5
Valvular Heart Disease

  • TAVI versus SAVR
  • Intervening in aortic stenosis
  • Assessing the tricuspid valve
  • Tricuspid valve disease

 

12:30Industry Sponsored Session12:30Industry Sponsored Session
13:15Lunch Buffet13:15Lunch Buffet
14:00

Session 2
Hypertension

  • 2024 ESC Hypertension Guidelines
  • RNA interference and other new drugs
  • Update on renal nerve ablation

 

14:00

 

14:30

 

 

 

 

The Paul Hamilton Wood Lecture

Session 6
Atrial Fibrillation and HF

  • The 2024 ESC Guidelines on AF
  • Stroke prevention
  • HF and renal disease

 

 

15:15Coffee  
15:45

Session 3
Imaging / Chronic Coronary Syndromes

  • Coronary imaging
  • Photon-based CT
  • 2024 ESC Guidelines on CCS
  • New therapeutic targets in CCS
  • HF drugs in patients with MI
16:15

Session 7
Cardiomyopathies

  • Hypertrophic cardiomyopathies
  • Amyloid heart disease
  • Sarcoidosis

 

 

 

 

 

17:45Networking Reception17:30Adjourn

 

Scientific Programme

Monday, December 9th, 2024 (UK time)

Venue: The Royal Society of Medicine

08:30 | Welcome Address 
 Welcome by the ESC PresidentThomas F. Lüscher, London

 

08:45 | Opening Lectures: Frontiers in Cardiovascular Science
Chair: Thomas F. Lüscher, London and Filippo Crea, Rome
08:45Opening Lectures 1:
Obesity: Managing an epidemic
John E. Deanfield, London
09:15Opening Lecture 2:
Artificial intelligence in cardiovascular medicine
Thomas F. Lüscher, London
09:45- 10:15 Coffee Break 

 

10:15 | Session 1: Risk Factors and Prevention
Chairs: John E. Deanfield, London and Andrew Krentz, London
10:15Global risk factor assessmentChristina Magnussen, Hamburg
10:35Genomics of cardiovascular risk factors    Heribert Schunkert, Munich
10:55Unmet needs in lipid managementLale Tokgözoğlu, Ankara
11:15Role of triglycerides as residual CV riskPeter Libby, Boston
11:35Diabetes: SGLT2 inhibitors, GLP1/GIP or both? (virtual talk)Nikolaus Marx, Aachen
11:55Panel DiscussionAll speakers from the session

 

12:30 - 13:15 | Industry-Sponsored symposium
13:15-14:00 Lunch Buffet

 

14:00 | Session 2: Hypertension
Chairs: Sofie Brouwers, Aalst and Vikas Kapil, London
14:00Blood Pressure Management: The new 2024 
ESC Hypertension Guidelines
John William McEvoy, Galway
14:20New innovations in drug therapy for hypertension Gianluigi Savarese, Stockholm
14:40Update on renal nerve ablation: Recommendations 
by the ESC and NICE
Sofie Brouwers, Aalst
15:00Panel DiscussionAll speakers from the session
15:15-15:45 Coffee Break 

 

15:45 | Session 3: Imaging / Chronic Coronary Syndromes
Chairs: Richard Grocott-Mason, London and Peter Libby, Boston
15:45Coronary imaging towards a non-stop shopCharalambos Antoniades, Oxford
16:05Photon-based CT: What is the clinical impact?Stephan Achenbach, Erlangen
16:25The new 2024 ESC Guidelines on Chronic Coronary Syndromes     Felicita Andreotti, Rome
16:45The need for new trials of old drugs: Betablockers and ACEi/ARB Bernard J. Gersh, Rochester MN
17:05Heart Failure drugs in patients with Myocardial InfarctionPeter van der Meer, Groningen
17:25Panel discussion    All speakers from the session
   
17:45    Cross-functional Networking Reception

Tuesday, December 10th, 2024 (UK Time)

Venue: The Royal Society of Medicine

08:30 | Session 4: Acute Coronary Syndromes and Cardiogenic Shock
Chairs: Felicita Andreotti, Rome and Shrilla Banerjee, Redhill
08:30Update on plaque rupture and erosion     Peter Libby, Boston 
08:50Coagulation and fibrinolysis as prognostic factors after ACSDiana Gorog, London
09:10Multivessel ACS: Culprit artery only or complete revascularisation?Marco Roffi, Geneva
09:30Cardiogenic shock: Balancing benefit and harm of LV unloadingChristian Hassager, Copenhagen
09:50DAPT versus SAPT after ACS: Update from recent trialsRobert Byrne, Dublin
10:10Panel discussionAll speakers from the session
   
10:30-11:00 Coffee Break 

 

11:00 | Session 5: Valvular Heart Disease
Chairs: Alison Duncan, London and NN
11:00TAVI versus SAVR: Which strategy in routine clinical practice?Bernard Prendergast, London
11:20Intervening in aortic stenosis: When is the right time?    Thomas F. Lüscher, London
11:40Assessing the tricuspid valveJeroen J. Bax, Leiden
12:00Tricuspid valve diseaseRalph S. von Bardeleben, Mainz
12:20Panel discussionAll speakers from the session

 

12:30 - 13:15 | Industry-Sponsored Symposium
13:15-14:00    Lunch Buffet

 

14:00 | The Paul Hamilton Wood Lecture
 
14:00The spectrum of Acute Coronary Syndromes Filippo Crea, Rome

 

14:30 | Session 6: Atrial Fibrillation and Heart Failure 
Chairs: Roxy Senior, London and Theresa McDonagh, London
14:30Managing atrial fibrillation: The 2024 ESC Guidelines    Isabelle van Gelder, Groningen
14:50Stroke prevention: LA occlusion or anticoagulation or both?
(virtual talk)
Ulf Landmesser, Berlin
15:10HF, diabetes and renal disease: The cardiometabolic conundrum (virtual talk)Nikolaus Marx, Aachen
15:30Panel discussionAll speakers from the session
15:45 - 16:15 Coffee Break 

 

16:15 | Session 7: Cardiomyopathies
Chairs: Bernard J. Gersh, Rochester MN and Eleanor Wicks, Oxford
16:15New Classification of cardiomyopathies:
What does it mean for clinical practice?
Eleanor Wicks, Oxford
16:35Amyloid heart diseaseMartha Grogan, Rochester MN
16:55Cardiac sarcoidosis    Rakesh Sharma, London 
17:15Panel discussionAll speakers from the session
   
17:30Wrap-up and AdjournThomas F. Lüscher, London

This event is supported by the pharmaceutical industry through sponsorship and the purchase of exhibition stand space. Sponsoring companies have no influence or are involved in the meeting programme, selection of speakers or venue.

AstraZeneca has provided a sponsorship towards this independent Programme.
AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.


 

Teaching Faculty

Stephan Achenbach
Erlangen, DE

Felicita Andreotti
Rome, IT

Charalambos Antoniades
Oxford, UK

Shrilla Banerjee
Redhill, UK

Jeroen J. Bax
Leiden, NL

Sofie Brouwers
Aalst, BE

Robert Byrne
Dublin, IE

Louise Clayton
Leicester, UK

Filippo Crea
Rome, IT

Simon Davies
London, UK

John E. Deanfield
London, UK

Alison Duncan
London, UK

Bernard J. Gersh
Rochester MN, USA

Diana Gorog
London, UK

Richard Grocott-Mason
London, UK

Martha Grogan
Rochester MN, USA

Christian Hassager
Copenhagen, DK

Vikas Kapil
London, UK

Andrew Krentz
London, UK

Ulf Landmesser
Berlin, DE

Peter Libby
Boston, USA

Thomas F. Lüscher
London, UK

Rajay Narain
Tooting, UK

Christina Magnussen
Hamburg, DE

Nikolaus Marx
Aachen, DE

Theresa A. McDonagh
London, UK

John William McEvoy
Galway, IR

Ana Naharro
London, UK

Bernard Prendergast
London, UK

Marco Roff
Geneva, CH

Gianluigi Savarese
Stockholm, SE

Heribert Schunkert
Munich, DE

Roxy Senior
London, UK

Rakesh Sharma
London, UK

Lale Tokgözoğlu
Ankara, TR

Peter van der Meer
Groningen, NL

Isabelle van Gelder
Groningen, NL

Ralph S. von Bardeleben
Mainz, DE

Eleanor Wicks
Oxford, UK


 

General Information

Registration

Registrations can be made exclusively online on our website: www.cardiologyupdate.uk

Category 
Registration fees 
Regular feeGBP 300
Early registration fee (until November 08, 2024)GBP 250
  
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)* 
Regular feeGBP 150
Early registration fee (until November 08, 2024)GBP 100
Day TicketGBP 150
  
Group Registration (For group registrations a minimum of 10 participants is required)** 
Regular feeGBP 260
Early registration fee (until November 08, 2024)GBP 210

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at nadine-estelle.abea@zhh.ch.

**Please contact Ms. Nadine-Estelle Kaltheuner (nadine-estelle.kaltheuner@zhh.ch) at the Zurich Heart House to obtain further information.

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancel-lation up to 1st of November 2024, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.

Venue

The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom

Organisation

Zurich Heart House, Foundation for Cardiovascular Research
Dr. Eleanor Wicks
Nadine-Estelle Abea
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90


 

Accreditation

The Cardiology Update London is recognised by the following institutions as accredited continuing education:

  • Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits
    14 category 1 (external) CPD credits
  • EACCME-UEMS European Accreditation Council for Continuing Medical Education (EACCME®)
    13 category 1 (external) CPD credits

EACCME

  • British Cardiovascular Society (submitted)

Sponsors

 

In collaboration with

Under the auspices of

Register here

Anmeldeschluss